Concept paper on the development of guidance on the non-clinical evaluation of radiopharmaceuticals - First version

  • Email
  • Help

Document details

Download document Concept paper on the development of guidance on the non-clinical evaluation of radiopharmaceuticals - First version
Reference number EMA/CHMP/SWP/545959/2016
Status draft: consultation open
First published 2017-08-01
Last updated 2017-08-01
Consultation start date 2017-08-01
Consultation end date 2017-10-31
Email address for submissions swp-h@ema.europa.eu

Summary

This concept paper is intended to seek external stakeholder views on potential guidance development related to overarching considerations for non-clinical data in support of clinical development and approval of radiopharmaceuticals. This guidance is intended to complement currently available guidelines (such as ICH M3(R2), ICH S6(R1), ICH S9 or the EMA Guideline on strategies to identify and mitigate risks for first-in-human clinical trials with investigational medicinal products) and includes the different intended uses of radiopharmaceuticals including radiodiagnostics as well as radiotherapeutics. The paper will focus on opportunities to targeted non-clinical programs according to specific development settings and product types and is not intended to duplicate guidance related to dosimetry.